Regulatory19 Jun 2026, 06:10 pm
Medplus Subsidiary's Drug License Suspended for One Day
AI Summary
Medplus Health Services Ltd announced that its subsidiary, Optival Health Solutions Private Limited, has received a one-day suspension order for a drug license for a store located in Telangana. The suspension, issued by the Assistant Director of Drugs Control Administration, Secunderabad, is due to a violation under Rule 65 of the Drugs and Cosmetics Act, 1940. The company estimates a potential revenue loss of approximately ₹0.47 lacs from this temporary suspension.
Key Highlights
- Subsidiary's drug license suspended for one day in Telangana.
- Violation cited under Drugs and Cosmetics Act, 1940.
- Estimated revenue impact of ₹0.47 lacs.
- Company to make details available on its website and stock exchanges.
Price Impact
More from MEDPLUS